Opportunistic Infection

Active Projects: 53

Project Investigator All Topics Start date
 		End date
Phase III Study: Safety & Efficacy of Daptomycin Compared to Conventional Therapy in the Treatment of Subjects w/ infective endocarditis or bacteremia due to Staphylococcus aureus Henry Chambers, MD Opportunistic Infection
PCP OPW Specimens Laurence Huang, MD Opportunistic Infection
SMART Anal Dysplasia Sub-Study Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Valley Fever Vaccine Project George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir Versus Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Recipients of Orthotopic Liver Transplants Opportunistic Infection, Pharmacology and Drug Treatment
Phase IV Open-Label, Non-comparative Trial of IV Anidulafungin followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Deferasirox (Exjade)-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Opportunistic Infection, Drug and Diagnostics Development
The Incidence of Bacillary Angiomatosis in Uganda Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
A8851009: A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used For Primary Therapy of Proven or Probable Invasive Aspergillosis Opportunistic Infection, Pharmacology and Drug Treatment
Protocol # ADMA-001: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial Evaluating the Safety and Efficacy of RI-001 in Medically Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Henry Chambers, MD HIV/AIDS, Opportunistic Infection
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Valley Fever Vaccine Project 2010 George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Gene Circuits that Control Morphology in Histoplasma Anita Sil, MD, PhD Infectious Disease, Opportunistic Infection
Task Order # 7: Supplement to SSS A5254 Diane Havlir, MD HIV/AIDS, Opportunistic Infection, Oral Health
Natural History and Outcomes of Coccidioidomycosis Retrospective Record Review Study Infectious Disease, Opportunistic Infection, Systematic Reviews and Guideline Development
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Diagnosis, Prevention, and Management of Cryptococcus Infection (Meningeal and Non-Meningeal) George Rutherford, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
WSA-CS-003: Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi Infectious Disease, Opportunistic Infection, Pharmacology and Drug Treatment
Host-pathogen Interactions during Vertical Transmission of Listeria monocytogenes Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Women's Health, Labor and Delivery, Newborn and Infant Health
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane Havlir, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health
Effects of Traffic Pollution on Lung Immunity and Pneumonia in Persons with HIV HIV/AIDS, Opportunistic Infection
Pathogenesis of HIV-Related Bacillary Angiomatosis HIV/AIDS, Opportunistic Infection, Infectious Disease, Cancer/Oncology
Evolution and Inhibition of Serine Beta-Lactamase Activity Adam Renslo, PhD Opportunistic Infection, Drug and Diagnostics Development
AIDS Education and Training Center (AETC) National Resource Center / Website Susan Coffey, MD HIV/AIDS, Opportunistic Infection, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
Bartonella: dissecting niche-specific adaptation in a human pathogen Opportunistic Infection
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients HIV/AIDS, Opportunistic Infection
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD HIV/AIDS, Opportunistic Infection
ACTG, AIDS Clinical Trial Research Group Diane Havlir, MD HIV/AIDS, Opportunistic Infection
Multi-Locus Sequence Typing Environmental Fungal Samples from Western Kenya Opportunistic Infection, Occupational and Environmental Disease
Regulatory Circuits That Link Cell Fate and Virulence in Histoplasma Capsulatum Opportunistic Infection
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph Derisi, PhD Infectious Disease, Opportunistic Infection
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer Jeffrey Martin, MD, MPH HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
The Connie Wofsy Women's HIV Study Ruth Greenblatt, MD HIV/AIDS, Opportunistic Infection, Women's Health
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium Robert Owen, MD Opportunistic Infection, Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
Transcriptional rewiring of aging pathways and dietary restriction effects in yeasts Opportunistic Infection
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Proteomics Analysis of Host-Pathogen Interactions in Histoplasma Anita Sil, MD, PhD Opportunistic Infection, Immunology
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Microbiome, Virome, and Host Responses Preceding Ventilator-Associated Pneumonia (VAP) Opportunistic Infection, Occupational and Environmental Disease, Pediatrics
AIDS Malignancy Consortium (AMC) Lawrence Kaplan, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
HPV testing of samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Regulatory circuits and virulence in candida albicans Opportunistic Infection
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia Steven Stoltz, MD Opportunistic Infection, Chronic Respiratory Disease
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
Elucidating the mechanism of macrophage death during infection with the AIDS-associated opportunistic pathogen Histoplasma capsulatum Anita Sil, MD, PhD HIV/AIDS, Opportunistic Infection
A Randomized Controlled Trial Evaluating Locally Administered Gentamicin in the Prevention of Deep Infection after Open Tibial Shaft Fractures in Tanzania David Shearer, MD Opportunistic Infection, Surgery and Anesthesia, Pharmacology and Drug Treatment